Sharif Alhassan Abdullahi

Dr. Sharif Alhassan Abdullahi

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2019 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
SASharif Alhassan Abdullahi
Sharif Alhassan Abdullahi
NUNgah Zasmy Unyah
Ngah Zasmy Unyah
NNNorshariza Nordin
Norshariza Nordin
RBRusliza Basir
Rusliza Basir
MWMohammed Nasiru Wana
Mohammed Nasiru Wana
RMRoslaini Abd. Majid
Roslaini Abd. Majid
Background. Toxoplasmosis remains widely distributed globally and is one of the major neglected parasitic zoonotic infections. The infection is still endemic in most parts of the world due to poor control as well as challenges of the currently used medications which can be overcome by using natural products. This study evaluated the effect of ethanolic extract from the stem of Tinospora crispa (EETC) on host cell invasion and intracellular replication of Toxoplasma gondii. Method. The stem powder of T. crispa was soaked in absolute ethanol for 72 hours. The resulting ethanolic extract was screened for the presence of phytochemicals. Vero cells monolayer in 96-well plate was infected with RH strain of T. gondii and treated with concentrations of the EETC, Veratrine alkaloid, and clindamycin ranging from 1.56 to 200 μg/mL. MTT assay was conducted after 24 hours to evaluate the cytotoxicity and antiparasitic activities of the EETC. Four and 24 hours treatment models were adapted to assess the infection index and intracellular proliferation of T. gondii in vitro. Microscopic analysis was conducted after 24 and 48 hours exposure to EETC in both treatment models. Results. The study revealed that the EETC had no cytotoxic effects on Vero cells with IC50 = 179 μg/mL, as compared to clindamycin (IC50 = 116.5 μg/mL) and Veratrine alkaloid (IC50 = 60.4 μg/mL). The EETC had good anti-toxoplasma activities with IC50 = 6.31 μg/mL in comparison with clindamycin (IC50 = 8.33 μg/mL) and Veratrine alkaloid (IC50 = 14.25 μg/mL). The EETC caused more than 70% and 80% reduction in infection index and intracellular proliferation in both treatment models, respectively. Conclusion. This in vitro study showed that the EETC contains promising phytochemicals effective against T. gondii and safe to the host cells.

27 May 2020 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
SASharif Alhassan Abdullahi
Sharif Alhassan Abdullahi
NUNgah Zasmy Unyah
Ngah Zasmy Unyah
NNNoshariza Nordin
Noshariza Nordin
RBRusliza Basir
Rusliza Basir
WNWana Mohammed Nasir
Wana Mohammed Nasir
RMRoslaini Abd. Majid
Roslaini Abd. Majid
Identification of drug target in protozoan T. gondii is an important step in the development of chemotherapeutic agents. Likewise, exploring phytochemical compounds effective against the parasite can lead to the development of new drug agent that can be useful for prophylaxis and treatment of toxoplasmosis. In this review, we searched for the relevant literature on the herbs that were tested against T. gondii either in vitro or in vivo, as well as different phytochemicals and their potential activities on T. gondii. Potential activities of major phytochemicals, such as alkaloid, flavonoid, terpenoids and tannins on various target sites on T. gondii as well as other related parasites was discussed. It is believed that the phytochemicals from natural sources are potential drug candidates for the treatment of toxoplasmosis with little or no toxicity to humans.

28 July 2021 in Metabolites
Verified
Journal Article
Open access
PDF file
AAASHRAF AHMAD ALAPID
ASHRAF AHMAD ALAPID
RMRoslaini Abd Majid
Roslaini Abd Majid
ZIZaid Ibraheem
Zaid Ibraheem
AMAhmed Mediani
Ahmed Mediani
IIIntan Safinar Ismail
Intan Safinar Ismail
RBRusliza Basir
Rusliza Basir
Andrographolide (AG) has been shown to have several medicinal and pharmaceutical effects, such as antimicrobial, anti-inflammatory, antioxidant, anti-diabetic, and anti-malarial activities. Moreover, studies to assess the pharmacological effect of AG on the metabolic changes of uninfected red blood cells (uRBCs) have not yet been investigated. This study aims to evaluate the pharmacological effects of AG compared to chloroquine (CQ) on the metabolic variations of uRBCs in vitro using a proton nuclear magnetic resonance (1H-NMR)-based metabolomics approach coupled with multivariate data analysis (MVDA). Forty-one metabolites were successfully identified by 1H-NMR. The results of the unsupervised data analysis principal component analysis (PCA) showed ideal differentiation between AG and CQ. PC1 and PC2 accounted for 71.4% and 17.7% of the explained variation, respectively, with a total variance of 89.10%. Based on S-plot and VIP values, a total of 28 and 32 metabolites were identified as biomarkers in uRBCs-AG and uRBCs-CQ, respectively. In uRBCs treated with AG, ten metabolic pathways were determined to be disturbed, including riboflavin metabolism, d-glutamate and d-glutamine metabolism, phenylalanine metabolism, glutathione metabolism, proline and arginine metabolism, arginine biosynthesis, citrate cycle, glycolysis/gluconeogenesis, and pyruvate metabolism as well as alanine, aspartate, and glutamate metabolism. In contrast, in CQ-treated uRBCs, nine affected metabolic pathways were determined, which involved the same metabolic pathways for uRBCs-AG, except for glutathione metabolism. These findings suggest an evident relationship between AG and CQ associated with metabolic changes in intact RBCs after being exposed to the treatment. The metabolomics results could allow useful comprehensive insights into the underlying mechanism of the action of AG and CQ on red blood cells. Consequently, the 1H-NMR-based metabolomics approach was successfully utilized to identify the pharmacological effects of AG and CQ on the metabolic variations of uRBCs.

13 February 2026 in Immunologic Research
Verified
Journal Article
Closed access
PDF file
MAMansur Aliyu
Mansur Aliyu
ASAli Akbar Saboor-Yaraghi
Ali Akbar Saboor-Yaraghi
MSMohamad Ali Sahraian
Mohamad Ali Sahraian
FNFarshid Noorbakhsh
Farshid Noorbakhsh
AAAl-Mukhtar Y. Yahuza Adamu
Al-Mukhtar Y. Yahuza Adamu
ZAZainab Abdulqadir
Zainab Abdulqadir

30 September 2023 in UMYU Scientifica
Verified
Journal Article
Open access
PDF file
SASharif Alhassan Abdullahi
Sharif Alhassan Abdullahi
HYHassan Yahaya
Hassan Yahaya
T. gondii was described as the most successful parasite on earth because of its wide range of host agents, intracellular adaptations and its ability to maintain continuous survival for the life span of its host. Its complex movement, penetration and intracellular replication within the host cell are organized in such a way that it invades and evades immune cells. Formation of parasitoporous vacoule within the host cells and strong anti-oxidant system, are factors that add to its ability to maintain itself in a latent stage, evasion of immune cells attack as well as the effects of reactive oxygen species. In immunocompetent individuals, the infection is asymptomatic, and the parasite exists and persists in a slowly replicating bradyzoite stage in skeletal muscle, heart, brain, retina, and placental tissues. Reactivation of the rapidly replicating tachyzoite stage in settings of immune-depression results with severe consequences. This, therefore, prompts the need to understand certain mechanisms through which this organism succeeds and adapts the harsh condition of host cells during infection. The review further portrays the applicability of diagnostics and therapeutics to diagnose, treat and prevent infection with T. gondii.

22 May 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
AUAniefiok John Udoakang
Aniefiok John Udoakang
DODaniel Oduro-Mensah
Daniel Oduro-Mensah
GAGloria Amegatcher
Gloria Amegatcher
OFONIKEPE FOLARIN
ONIKEPE FOLARIN
IIsah Abubakar Aliyu
Isah Abubakar Aliyu
PQPeter Kojo Quashie
Peter Kojo Quashie
Background: Africa seemed to have had low SARS-CoV-2 infection and COVID-19 morbidity and mortality. While several studies reported high SARS-CoV-2 seropositivity among healthy Africans, others hypothesized that this could have resulted from pre-existing cross-reactive antibodies. Our study tracks trends in seropositivity across three West African countries during the Delta and Omicron pandemic waves using a validated test kit with 98.9% predictive accuracy, 97% sensitivity, and 99% specificity.Methods: Cross-sectional studies were conducted across three West African countries (Burkina Faso, Ghana, and Nigeria) with study sites conveniently selected in each country. Using the validated immunoassay kits, with already published validation procedures, SARS-CoV-2 antibodies were detected in peripheral blood during the ‘Delta’ and ‘Omicron’ waves. Participants' demographic and clinical data were obtained using a semi-structured questionnaire, and the primary outcome was the proportion of each population with SARS-CoV-2 antibodies.Findings: Across the 3 countries, 20,748 participants were recruited, and the results showed SARS-CoV-2 IgG seropositivity ranging between 24.1% to 77.0%, which increased during the Omicron wave. All sites showed low self-reported vaccination rates, delinking seropositivity and vaccination. While there was a significant positive association between seropositivity and age across all sites, the association with other demographic factors was country-dependent, and most participants expressed positive opinions of vaccination.Interpretation: This is one of the largest population-based SARS-CoV-2 seroepidemiology studies in Africa, confirming widespread mild SARS-CoV-2 infection in West Africa. This confirms a marked disconnect between high population exposure and low reported clinical burden, underscoring the need for strengthened community surveillance.